Autopsy report · NCT04795856

Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)

“lack of recruitment and PI departure”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

University of Alabama at Birmingham

Sponsor type

University, hospital or other

Conditions

Mitral Valve Regurgitation

Interventions

[11C] acetate

Participants

0

Trials that died the same way

• Evaluation of the Influence of Body Position on the Inferior Vena Cava (IVC) Diameter
  “Poor recruitment, PI leaving university” (82% match in meaning)
• Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis
  “Lack of recruitment” (77% match in meaning)
• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
  “lacking recruitment” (74% match in meaning)
• Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task Practice
  “PI has encountered recruitment challenges.” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.